Valuation: Cosmos Health Inc.

Capitalization 18.32M 15.79M 14.7M 13.68M 25.48M 1.66B 27.41M 169M 66.67M 793M 68.68M 67.27M 2.89B P/E ratio 2025 *
-1.54x
P/E ratio 2026 * -4.77x
Enterprise value 18.32M 15.79M 14.7M 13.68M 25.48M 1.66B 27.41M 169M 66.67M 793M 68.68M 67.27M 2.89B EV / Sales 2025 *
0.28x
EV / Sales 2026 * 0.19x
Free-Float
84.49%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-3.19%
1 week-4.62%
Current month+5.32%
1 month+4.50%
3 months-51.88%
6 months+16.35%
Current year+5.32%
More quotes
1 week 0.42
Extreme 0.416
0.58
1 month 0.42
Extreme 0.416
0.58
Current year 0.42
Extreme 0.416
0.58
1 year 0.28
Extreme 0.2801
1.32
3 years 0.28
Extreme 0.2801
7.44
5 years 0.28
Extreme 0.2801
225
10 years 0.28
Extreme 0.2801
312.5
More quotes
Manager TitleAgeSince
Chief Executive Officer 60 25/02/2016
Director of Finance/CFO 44 10/11/2020
Chief Operating Officer - 31/01/2023
Director TitleAgeSince
Director/Board Member 59 12/01/2014
Chairman 60 25/02/2016
Director/Board Member 60 17/11/2016
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-3.19%-4.62%-37.19%-86.34% 18.32M
-0.43%+2.99%+41.21%+120.13% 104B
-0.47%+5.64%+67.24%+176.38% 50.48B
+1.40%+0.35% - - 22.28B
-0.54%-2.40%+17.07%-21.49% 9.71B
-1.03%-2.91%-11.34%-7.31% 8.35B
+0.88%-0.29%+0.83%+2.84% 8.25B
+3.15%+3.75%+15.43%+75.38% 6.95B
-0.51%-0.15%+25.78%+31.33% 6.1B
Average -0.08%+0.27%+14.88%+36.36% 23.99B
Weighted average by Cap. -0.12%+2.68%+41.38%+112.77%
See all sector performances

Financials

2025 *2026 *
Net sales 64.4M 55.52M 51.68M 48.12M 89.59M 5.84B 96.39M 595M 234M 2.79B 242M 237M 10.18B 98.6M 85M 79.13M 73.67M 137M 8.95B 148M 910M 359M 4.27B 370M 362M 15.58B
Net income - -
Net Debt - -
More financial data * Estimated data
Logo Cosmos Health Inc.
Cosmos Health Inc. is a global healthcare company. The Company owns a portfolio of pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe and C-Sept. Through its subsidiary, Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It distributes a line of pharmaceuticals and Para pharmaceuticals, including branded generics and over the counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It is also engaged in the research and development (R&D) of patented nutraceuticals and specialized root extracts as well as in the R&D of complex generics and OTC products. It offers Cloudscreen, a multimodal platform specialized in drug repurposing, a process of uncovering new target proteins. It is also specialized in the storage and distribution of pharmaceutical and Para pharmaceutical goods.
Employees
149
More about the company
Date Price Change Volume
16/01/26 0.5245 $ -3.19% 1,144,658
15/01/26 0.5418 $ +21.53% 6,804,605
14/01/26 0.4458 $ -4.66% 2,573,529
13/01/26 0.4676 $ -7.15% 1,544,030
12/01/26 0.5036 $ -8.42% 990,680

Delayed Quote Nasdaq, January 16, 2026 at 09:00 pm

More quotes

Quarterly revenue - Rate of surprise